Portfolio company
Motif Neurotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
8 investors
Sectors
About
Motif Neurotech develops a miniature implantable brain stimulator providing at-home therapy for patients with treatment-resistant depression and other mental health disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Inner Cosmos
This company develops a minimally invasive brain-computer interface implant to treat cognitive disorders for patients suffering from depression.
Mindspire
This company develops a wearable earpiece for personalised vagus nerve stimulation to help patients manage chronic stress, neurological conditions and mental health performance.
Magnus Medical
Magnus Medical develops a brain stimulation system to treat patients with major depressive disorder within clinical healthcare settings.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Salvia BioElectronics
This company develops thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraine and other neurological conditions.
Salvia
The company develops minimally invasive, ultra-thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraines.
Neuroharmonics
This company develops non-invasive ultrasound devices to modulate deep brain circuits for patients with movement disorders, depression, chronic pain, and addiction.
Sooma Medical
This company develops portable brain stimulation devices and digital platforms for clinicians to treat patients with depression and chronic pain.
